Clascoterone and Testosterone Interaction
Clascoterone and Testosterone have an interaction requiring monitoring for interaction with 60% confidence. Both Clascoterone and Testosterone carry androgenic activity. Additive androgenic load increases risk of acne, hair loss, and prostate effects. Monitor for dose-dependent side effects. These compounds primarily affect different organ systems.
Compound Profiles
Clascoterone
Topical Androgen Receptor Inhibitor | Acne & Hair Loss
Clascoterone acts as a competitive antagonist of the androgen receptor (AR). When applied topically, it penetrates the skin and binds directly to androgen receptors in target tissues -- sebaceous glands (for acne) and dermal papilla cells of hair follicles (for alopecia).
View full profileTestosterone
Anabolic-Androgenic Steroid | Primary Male Sex Hormone
Testosterone exerts its effects primarily through binding to the intracellular androgen receptor (AR), forming a hormone-receptor complex that translocates to the nucleus and modulates gene transcription. This drives protein synthesis in skeletal muscle (anabolic effect), stimulates erythropoietin production in the kidneys to increase red blood cell mass, promotes osteoblast activity and bone mineral density, and regulates libido and cognitive function.
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take Clascoterone with Testosterone?
Yes, but with caution. Both Clascoterone and Testosterone carry androgenic activity. Additive androgenic load increases risk of acne, hair loss, and prostate effects. Monitor for dose-dependent side effects. Regular monitoring is advised.
Is Clascoterone and Testosterone safe together?
Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: androgenic, teratogenic. Monitor accordingly.
What are the interactions between Clascoterone and Testosterone?
Both Clascoterone and Testosterone carry androgenic activity. Additive androgenic load increases risk of acne, hair loss, and prostate effects. Monitor for dose-dependent side effects. This assessment has 60% confidence and is inferred from pharmacological mechanism analysis.
How should I time Clascoterone and Testosterone?
Clascoterone has a half-life of Short topical (local action; rapidly metabolized to cortexolone) and Testosterone has a half-life of ~8 days (cypionate). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.